FDA issues an Early Communication About an Ongoing Safety Review of Vytorin, Zocor, and Zetia.
This is a discussion on FDA issues an Early Communication About an Ongoing Safety Review of Vytorin, Zocor, and Zetia. within the FDA News forum, part of the Industry News and Updates category; FDA issues an Early Communication About an Ongoing Safety Review of Ezetimibe/Simvastatin (marketed as Vytorin), Simvastatin (marketed as Zocor) ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
08-22-2008, 03:44 PM
|
|||
|
|||
FDA issues an Early Communication About an Ongoing Safety Review of Vytorin, Zocor, and Zetia.
FDA issues an Early Communication About an Ongoing Safety Review of Ezetimibe/Simvastatin (marketed as Vytorin), Simvastatin (marketed as Zocor) and Ezetimibe (marketed as Zetia).
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| FDA issues Complete Response letters ordering Safety Labeling Changes under FDAAA for Aranesp, Epogen, and Procrit | industry_news | FDA News | 0 | 07-30-2008 06:45 PM |
| FDA issues an Early Communication About an Ongoing Safety Review of Tumor Necrosis Factor (TNF) Blockers (marketed as Re | industry_news | FDA News | 0 | 06-07-2008 07:30 PM |
| CDER issues "Review of Therapeutic Equivalence Generic Bupropion XL 300 mg and Wellbutrin XL 300 mg" | industry_news | FDA News | 0 | 04-17-2008 06:51 PM |
| FDA issues an Early Communication about an Ongoing Safety Review for Botox | industry_news | FDA News | 0 | 02-26-2008 03:30 PM |
| FDA Issues Early Communication about an Ongoing Review of Vytorin | industry_news | FDA News | 0 | 02-26-2008 03:30 PM |
© 2008 DrugManagementForum™ powered by |
 |